TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Ariad Pharmaceutical's Iclusig May Relieve Shareholders' Pain: StockTwits
OPINION

Mallinckrodt Is Just One Of Dennis Kozlowski's Billion Dollar Babies

Ventas Sells Majority Stake in Ardent's Hospital Operations to Zell PE Firm
MERGERS AND ACQUISITIONS

Mallinckrodt Inks $1.3B Deal for Cadence

Dating Sites: Best, Worst & Weirdest
INVESTING

Mallinckrodt Buys Cadence Pharma for $1.3 Billion

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS

Biotech Stocks Partying Like It's 1999

3 Stocks Breaking Out on Unusual Volume
INVESTING

8 Stocks Under $10 Trending Sharply Higher

5 Stocks Insiders Love Right Now
INVESTING

4 Health Care Stocks Under $10 to Watch

5 Hated Earnings Stocks You Should Love
INVESTING

5 Stocks Poised for Breakouts

4 Big-Volume Stocks to Trade for Breakouts: Crocs, Rovi and More
INVESTING

5 Stocks Under $10 Triggering Breakouts

Stocks Under $5: Discount Drug Name
VIDEO

Stocks Under $5: Discount Drug Name

Consider Buy Rated Stocks Under Five Bucks as Stocking Stuffers
MARKETS

8 Stocks Under $10 Making Big Moves

Dating Sites: Best, Worst & Weirdest
STOCKS

Cadence Pharmaceuticals' Management Presents At The 2012 Wedbush PACGROW Life Sciences Management Access Conference (Transcript)

Dating Sites: Best, Worst & Weirdest
STOCKS

Cadence Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

Oracle Rises to the Cloud, While Jabil Goes to the Woodshed
MARKETS

7 Stocks Under $10 With Relative Strength

5 Bargain Bin Stocks to Buy in March
INVESTING

8 Stocks Under $10 to Avoid at All Costs

Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

Biotech Stock Mailbag: 2011 Report Card

Steve Rosenman Says Amarin Has Sticky Web Eyeballs!
STOCKS

Pacira: Exparel Approval Easy, Selling Painkiller Harder Challenge

First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast
STOCKS

10 Most Shorted Stocks in Biotech

Hedge Funds Love These 5 Consumer Stocks -- but Should You?
INVESTING

5 Stocks Showing Relative Strength in a Weak Market

Furiex Pharma Diarrhea Drug Produces Solid Results in Pivotal Studies
STOCKS

Biotech Stock Mailbag: Cadence Pharma

Vertex Cures Hard-to-Treat Hep C Patients
STOCKS

Biotech Sector Weekly Rewind

FDA to Review Amgen Drugs: BioBuzz
STOCKS

Biotech Sector Weekly Rewind

Dating Sites: Best, Worst & Weirdest
STOCKS

Cadence CEO Discusses Q3 2010 Results - Earnings Call Transcript

STOCKS

Cadence: When A Drug Approval Sinks Stock

FDA to Review Amgen Drugs: BioBuzz
STOCKS

FDA Ends October With Drug Approvals, Rejection

Novartis Commits $500 Million to Russia
STOCKS

Biotech Calendar: Key Dates for November